Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Review

TREC to WHERE? Transdisciplinary Research on Energetics and Cancer

Kathryn H. Schmitz, Sarah Gehlert, Ruth E. Patterson, Graham A. Colditz, Jorge E. Chavarro, Frank B. Hu, Marian L. Neuhouser, Kathleen M. Sturgeon, Mark Thornquist, Deirdre Tobias and Linda C. Nebeling
Kathryn H. Schmitz
1Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Schmitz@mail.med.upenn.edu
Sarah Gehlert
2Siteman Cancer Center, Washington University in St. Louis, St. Louis, Missouri.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruth E. Patterson
3Moores Cancer Center, University of California at San Diego, San Diego, California.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graham A. Colditz
2Siteman Cancer Center, Washington University in St. Louis, St. Louis, Missouri.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jorge E. Chavarro
4Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank B. Hu
4Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marian L. Neuhouser
5Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathleen M. Sturgeon
1Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Thornquist
5Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deirdre Tobias
4Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda C. Nebeling
6NCI, Rockville, Maryland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-14-1214 Published April 2016
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

When information is exchanged across disciplinary boundaries, resources are shared, and discipline-specific approaches are altered to achieve a common scientific goal, we create a new intellectual space for transdisciplinary research. This approach, fostered heavily by multiple NCI-funded initiatives, has the potential to forge new understanding of major public health issues. By breaking down disciplinary barriers, we work toward making real, meaningful, and lasting forward motion in addressing key public health issues. One of the transdisciplinary initiatives of the NCI is TREC: Transdisciplinary Research on Energetics and Cancer. In this article, we review the goals and scope of TREC, as well as the ways in which the initiative promotes transdisciplinary science. A particular focus is on multiple examples of the most unique aspect of the initiative: the funding of developmental projects across multiple TREC centers, toward the goal of incubating high-risk science that has the potential to translate into major leaps forward in understanding energetics in cancer. As we enter an era of greater focus on investigator-initiated science, new approaches may be needed to ensure that the peer review process is not solely organized along disciplinary lines. Inclusion of expertise regarding transdisciplinarity, as well as representation from multiple scientific disciplines within a panel, may allow transdisciplinary research to receive an educated hearing. The body of researchers trained to work in a transdisciplinary research space is ideally suited to address these challenges. Clin Cancer Res; 22(7); 1565–71. ©2016 AACR.

Introduction

Transdisciplinary research gained attention in the late 1990s when the NCI mandated its use in funding initiatives aimed at addressing tobacco use, cancer communications, cancer disparities, and energy balance in cancer (1–4). The last of these initiatives is a U54 cooperative agreement called Transdisciplinary Research in Energetics and Cancer (TREC). TREC was first funded in 2005 and is in its second round of funding (3). The impetus for the development of TREC was a desire to capture the multilevels of influence of energy balance in cancer control outcomes by including transdisciplinary scholars from the social, behavioral, and biologic sciences on integrated teams. As part of this cooperative agreement, NCI scientists partner with TREC investigators to work jointly to support and stimulate activities.

The TREC initiative has two main goals, namely to enhance knowledge of the current mechanisms underlying the association between energy balance and carcinogenesis (from cellular, animal or human models to genetics and genomics and across the cancer continuum from causation and prevention to survivorship and recurrence) and to explore and integrate the etiology of obesity behavior and relevant health behavior theories, with broad population impact at the social–environmental and policy levels for prevention and control of obesity.

Rosenfield defines transdisciplinary research as research in which information is exchanged, resources are shared, and discipline-specific approaches are altered to achieve a common scientific goal (5). It is posited that this approach will achieve the highest degree of disciplinary collaboration. In this approach, scholars begin to transcend their disciplinary boundaries to create new intellectual space. The approach has the potential to forge new understandings of major public health problems like energetics and cancer by breaking down the usual barriers to collaboration. Emmons and colleagues use energetics and cancer as an example of the inefficiency that occurs when boundaries between the social, behavioral, and biologic sciences are rigidly maintained in research, saying, “If the primary focus of work in obesity and energy balance is on sociocultural factors, eventually the limits of not considering both environmental and physiologic factors will be realized” (6).

The TREC sites have leadership in a variety of disciplines, including molecular biology, genetics, oncology, psychology, nutrition, epidemiology, exercise physiology, biostatistics, social epidemiology, geography, social work, sociology, behavioral psychology, economics, cancer biology, and computer science. The TREC Steering Committee encompasses many areas of expertise, and more investigators have been brought in when additional expertise was needed. By meeting frequently, the group's steering committee, made up of the directors and codirectors of the TREC sites, in partnership with NCI scientists and administrative program staff, has been able to establish common goals of the initiative, exemplified by its mission statement: “….to integrate diverse disciplines to find effective interventions across the lifespan to reduce the burden of obesity and cancer and to improve population health” (7).

The NCI transdisciplinary team science initiatives, including TREC, have allowed for the creation of scientific communities that have reshaped the way problems are conceptualized and approached, based on the development of deep collaboration of individuals across the transdisciplinary continuum. In addition to the transdisciplinary research occurring within each site, new scientific communities have been fostered. Each site was required to have an education, training, and outreach core to provide opportunities for professional development of TREC trainees, including pre- and post-docs, as well as junior faculty. TREC trainees receive mentoring in transdisciplinary science relevant to the initiative and are invited to participate in working groups and to apply for developmental pilot funds in collaboration with a more senior faculty mentor. More detail on the TREC approach to supporting career advancement for trainees is available elsewhere (8, 9).

Working groups were defined on the basis of the shared interests of TREC members, and bring together scientists interested in similar issues (e.g., health disparities, biomarkers) for monthly conference calls. Frequent in-person scientific meetings are used to share updates on science within and beyond TREC. A coordinating center provides a support framework, enabling teams to focus on science rather than logistics. But perhaps the most important mechanism is the funding of the cross-TREC developmental pilot projects. During years 2 through 5, funding was available for up to two cross-TREC developmental pilot projects with funding of approximately $30,000 per site. These projects required the inclusion of at least two scientific disciplines and at least two TREC sites (but up to five, including the coordinating center) for science that was clearly transdisciplinary in scope. The TREC steering committee prioritized cross-TREC developmental pilot funds toward transdisciplinary projects that would result in future funding. Below, we review examples of how TREC has allowed participating researchers and trainees to think differently about their science and positively influence the scope and quality of scientific discovery. Although over 10 examples were available from which to choose (See Table 1), the examples presented below were chosen because we believe that they best highlight unique features of TREC. Table 1 provides a summary of the focus of all of the Cross-Center Developmental pilot projects, including involvement of TREC trainees, disciplines involved, and the common processes used by each project to foster collaboration among researchers from disparate disciplines to work toward a common goal.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1.

Summary of cross-TREC developmental projects

Examples of TREC Projects

The potential for exercise to attenuate the increased risk for breast cancer due to delayed parity

This project was funded as one of the 1-year cross-TREC developmental projects in the current round of funding (2011–2016). Earlier age at menarche and later age at first pregnancy are consistently associated with higher risk of breast cancer (10–12), and evidence from epidemiology, reproductive epidemiology, and breast oncology suggests the interval between these two reproductive events has lengthened in recent years (13–16). An interaction of breast cancer risk levels has been observed when examining the interval between menarche and first pregnancy and alcohol intake during this time period (17). This supports the potential modifying effect of additional lifestyle factors on breast cancer risk. Identifying lifestyle interventions to mitigate the excess risk associated with a longer interval between menarche and first pregnancy brings together the disciplines of exercise physiology, nutritional epidemiology, developmental biology, and nutritional epidemiology, and would have global public health implications.

Convincing epidemiologic evidence exists associating moderate-to-vigorous intensity physical activity with a 10% to 25% lower risk of breast cancer, compared with inactivity (18, 19). A similar benefit is observed in well-controlled animal models of experimentally induced mammary carcinogenesis (20, 21). However, we do not yet know whether physical activity can offset the risk of breast cancer associated with a longer interval between menarche and first pregnancy. One of the aims of this project is to analyze existing prospective data from 63,448 women in the Nurses' Health Study II to evaluate the interaction between length of the interval between menarche and first pregnancy and physical activity on breast cancer risk, with detailed longitudinal information on diet, lifestyle, and health-related outcomes. This analysis required the expertise of biostatistics, epidemiology, exercise physiology, gynecology, and cancer biology. A second aim of this study is to investigate a rat model of exercise and delayed parity by examining changes in the gene expression levels associated with early pregnancy–induced protection against mammary tumorigenesis. The collaborative team's development began when two postdoctoral fellows (an exercise physiologist and an epidemiologist) began discussions about this project at an in-person TREC meeting. They sought the mentorship of senior TREC faculty in biostatistics, cancer biology, and gynecology to shape their application for funding. Once awarded, they employed the common processes outlined in Table 1 to successfully complete this transdisciplinary project.

Developmental origins of cancer: Effect of in utero exposures on offspring risk for prostate cancer

In our next example, a cross-TREC developmental study arose out of collaborations between scientists leading within-center projects at two of the TREC sites (Washington University and Harvard University). Using a rodent model, a Washington University project led by an obstetrican/gynecologist who specializes in murine modeling aims to identify whether exposing female mice throughout pregnancy to a high-fat diet (HFD), is associated with epigenetic alterations of imprinted genes in prostate tissue at 8, 16, 26, 34, and 53 weeks postnatal. The lead investigator sought advice from a molecular biologist at Washington University to pursue the investigation. Loss of imprinting (LOI) in IGF2, one of the genes under investigation, has been implicated in breast and prostate carcinogenesis. The project, which added nutritional and other epidemiologists to its research team, will generate data on whether maternal diet can influence LOI in this gene throughout the lifetime. Yet, whether this mechanism applies to other common cancers and the extent to which the findings from this rodent model are translatable to humans are unknown. Therefore, a cross-TREC developmental project was funded to examine the generalizability of this molecular mechanism to breast cancer using a rodent model. In addition, another cross-TREC team is evaluating the translatability of the findings of these two rodent models to humans using data from a prenatal cohort. Specifically, this team, which now includes cancer biologists, molecular and nutritional epidemiologists, as well as a biostatistician, is examining whether (i) the effects of HFD on the methylation of IGF2 and H19 in the mouse prostate are also observed in mouse white blood cells. (Washington University in St. Louis center); (ii) HFD is related to methylation of IGF2 and H19 in the mouse mammary fat pad and white blood cells (University of California San Diego center); and (iii) second-trimester human maternal fat intake (total fat intake and intake of major types of fat) is related to methylation of IGF2 and H19 in cord blood white blood cells (Harvard University center).

Inflammation as a mechanism for differences in breast cancer by race and obesity

This activity was funded as a year 3 cross-TREC developmental project. Interest has grown in understanding the association of the tumor microenvironment with breast cancer severity. Under chronic inflammation, T lymphocytes, macrophages, and neutrophils contribute to increased cell proliferation and inhibition of cell death, potentially advancing cancer. The presence of these immune cells in tumor samples may indicate aggressive tumors that are likely to metastasize. Obesity is a risk factor for postmenopausal breast cancer and reduced response to endocrine therapy that has been associated with chronic inflammation (22–26). The majority of breast cancer tumors are estrogen receptor positive (ER+). Estrogen secreted from adipose tissue promotes ER+ tumor growth, making obesity a prominent factor in ER+ tumorigenesis (27). African-Americans face a heightened risk of obesity and poor breast cancer outcomes, but the relationship between these disparities is not fully understood and it is unclear what mechanisms drive this association (25, 28–33). Because it is unlikely that environmental differences account for all of the disparity observed in breast cancer outcomes, biologic mechanisms that place groups at high risk for aggressive disease must be considered. Higher rates of obesity increase underlying inflammation and may be a mechanism that contributes to ER+ breast cancer disparities. This cross-TREC developmental project examines the contribution of obesity to inflammation in the tumor microenvironment, given that it may explain the racial disparity in ER+ breast cancer. Inflammation biomarkers in ER+ breast cancer tumors are being examined across a range of body mass indices (BMI) in postmenopausal African-American and White women. The study hypothesizes that higher BMI increases the presence of lymphocytes, macrophages, and neutrophils within the ER+ breast tumor microenvironment and that race modifies the association of inflammation biomarkers with BMI in ER+ breast cancer tumors. The team is linking pathologic examinations of inflammation in tumor specimens to clinical data. The team has acquired breast cancer tissue from African-American and White postmenopausal patients at four TREC sites for this study. A pathologist at the University of Pennsylvania is examining existing formalin-fixed, paraffin-embedded breast tissues from each TREC site, using standardized protocols, for automated scoring of tumoral lymphocytes, macrophages, and neutrophils, and noting the type and number of these immune cells. The significance of this study is that factors affecting race differences in the tumor microenvironment of breast cancer patients evaluated by BMI have not been described. Complementing ongoing work in cancer inflammation and disparities, these researchers will link pathologic examinations of inflammation in breast tumor specimens to clinical and questionnaire data. The quantification of changes in the tumor microenvironment by BMI and race may provide tumor signatures to improve breast cancer prognostics. The long-term objective of this work is to identify ways to improve treatments for women at high risk for poor outcomes by modifying inflammatory markers in the tumor microenvironment via dietary and/or exercise interventions. If patients can be better classified in terms of risk for metastasis, treatments can be tailored to prevent over- or undertreatment of patients via adjuvant chemotherapy (30).

Transdisciplinary intersection of geospatial and social sciences

The TREC Spatial and Contextual Methods and Measures Working Group established a series of cross-center developmental projects around the objective measurement of health behavior and the built environment. One study added state-of-the-science accelerometers and global positioning system (GPS) devices to a subsample of participants drawn from the four TREC sites. This provided additional behavioral and environmental data for each site and worked to advance the science of objective contextualized (behavior and location) assessment of physical activity, sedentary behavior, and sleep—behavioral and environmental exposures related to cancer risk. The exchange of ideas and experience across sites improved the capacity of each center to measure multiple behaviors in context and to apply this to larger cohorts.

A subsequent developmental project was built on these data to advance the methods in this area. The aims of the project were to identify behavior measurement error due to four spatially related factors (e.g., missing GPS data) and to assess the effects of these errors on the outcome measurement of physical activity and sedentary behavior. The researchers developed a first-of-its-kind, shared, HIPAA-compliant secure environment for processing massive GPS datasets with complex spatial layers that can expand based on processing demands. This work forms a model for future collaborations.

The cross-center collaborations and the amount of resulting measurement data provide opportunities for advancing the science of behavior and contextual measurement. A third developmental project aims to use existing accelerometry data to derive circadian rest–activity patterns, examine how these patterns are associated with demographic characteristics, and develop novel field methods for capturing the influence of environmental cues using a mobile application.

TREC Framework and Future Directions

The NCI has supported a network of five sites (four research centers and a coordinating center) to facilitate new collaborative endeavors and address knowledge gaps. This network has a common understanding that the relationships among obesity, exercise, diet, and cancer outcomes are too complex to be addressed by a single scientific discipline. As such, the challenge includes bringing together scientists with widely differing methodologic training and assumptions toward the goal of answering “big” questions. An infrastructural framework has been developed to assist these teams in developing functional working relationships and to foster a common understanding of the shared transdisciplinary goals of the initiative (34). The infrastructural framework developed out of the lessons learned from the first round of the initiative and includes the steering committee capacity, the coordinating center infrastructure, site-specific capacity, and cross-center shared activities (Fig. 1).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Conceptual framework for developing the TREC transdisciplinary research community.

The cross-TREC developmental projects reviewed herein demonstrate novel transdisciplinary work that integrates social, behavioral, and biologic sciences to advance the pace of discovery. The formation of the TREC community has allowed participating researchers to take advantage of resources, expertise, and relevant methodologies or technologies not available at any one site and to minimize effort duplication and more efficiently use existing resources. The TREC initiative has integrated public use assessment tools and combined established datasets, patient/participant cohorts, and clinical care networks. These activities would not have been possible without the formation of the TREC network and the developmental project funding. In addition, we have been able to extend our approach and findings to new cancer sites and to address important research questions not initially anticipated at the onset of funding, such as the intersection of obesity, cancer, and race/ethnicity.

TREC was able to include areas of transdisciplinary building and management into its operations (35–39). Lessons learned in the first round of TREC have been particularly useful for this round of funding to move more quickly into transdisciplinarity (38). Building and sustaining the transdisciplinary capacity in an organization is an ongoing challenge. Leadership at each site, and the individual site administrative leadership, can encourage transdisciplinarity capacity. The way centers/sites/partners and the Steering Committee organize themselves can facilitate leadership models that engage a transdisciplinary approach. The TREC Steering Committee worked together to tackle common team science/team building issues and identify common goals to be applied across the centers. We identified common transdisciplinary goals, as well as a common mission and vision. This translated into development of cross-center research priorities and needs. We developed common resources to facilitate aspects of team development and education to facilitate cross-center collaborations. Finally, the Steering Committee incorporated a transdisciplinary leadership style to address issues related to decision making, problem solving, conflict resolution, information exchange, coordination, and boundary management. Essentially, the members of the TREC Steering Committee and the TREC Center's individual leadership were able to glean from lessons learned from prior transdisciplinary center initiatives, as well as information from the science of building teams and/or transdisciplinary science literature, plus individual executive advisory groups, and incorporate aspects of leadership and management to effectively develop and maintain transdisciplinary collaborations within and across sites. TREC has had input from experts in the science of team science along the way, as well as the benefit of lessons learned from NCI initiatives that occurred before TREC 2. An additional consideration has been how the academic leadership within individual organizations embraced the ideas behind the TREC collaboration/centers and what type of in-kind support was offered. On the basis of experience, the most successful transdisciplinary centers have occurred when BOTH the initiative's Steering Committee/leadership and the individual site's academic leadership were supportive and took extra steps to facilitate the transdisciplinary approach. All of this was made possible by the U54 mechanism and would have been difficult to capture with either a P01 or a U01 mechanism.

Conclusions

“Universities have departments, the real world has problems” (40). As illustrated by the examples given above, transdisciplinary research on energetics and cancer offers the promise of novel, wide-reaching, and important discoveries. However, transcending the familiar boundaries of disciplinary silos poses considerable challenges. In transdisciplinary projects, misunderstandings and disagreement are more likely (41). Differences among scientists about the validity of each other's conceptual frameworks, mismatches between rewards stressing disciplinary competence over innovation, and institutional disincentives can impede successful transdisciplinary endeavors (41). Success may also be elusive if transdisciplinary teams lack a common problem focus. Finally, the absence of processes for decision making, problem solving, conflict resolution, information exchange, coordination, and boundary management can be detrimental to collaboration (41).

The NCI has been a leader in supporting transdisciplinary team science (35–39). In particular, the TREC initiative offers an efficient and effective framework to help scientists conduct transdisciplinary research on obesity and cancer and train new and established scientists to carry out this type of integrated research. The TREC initiative ensures that the research group has a common focus on using transdisciplinary science to address problems related to energetics and cancer. TREC's governance structure provides formal and informal processes for information exchange and problem solving and ensures that critical cross-center and cross-discipline relationships are built on trust and mutual respect. Finally, as per the examples herein, the requirement to fund and conduct cross-center research projects brings together experienced and new researchers to engage in exciting, high-risk transdisciplinary projects.

In the modern era of greater focus on investigator-initiated science, one challenge to extramural investigators and their NCI scientific colleagues will be to create new mechanisms that will allow transdisciplinary research to continue to flourish and grow. New approaches may be needed to ensure that the peer review process is not solely organized along disciplinary lines. Inclusion of expertise regarding transdisciplinarity, as well as representation from multiple scientific disciplines within a panel, may allow transdisciplinary research to receive an educated hearing. There are challenges ahead for transdisciplinary research, but they are welcome ones. The NCI intended to jump start a field and indeed it has: Transdisciplinary research is here to stay.

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Grant Support

This work was supported by the NCI Centers for TREC [U01 CA116850 (Coordination Center), U54 CA155626 (Harvard University), U54 CA155435 (University of California, San Diego), U54 CA155850 (University of Pennsylvania), and U54 CA155496 (Washington University)].

  • Received May 12, 2014.
  • Revision received October 21, 2015.
  • Accepted October 21, 2015.
  • ©2016 American Association for Cancer Research.

References

  1. 1.↵
    1. Morgan GD,
    2. Kobus K,
    3. Gerlach KK,
    4. Neighbors C,
    5. Lerman C,
    6. Abrams DB,
    7. et al.
    Facilitating transdisciplinary research: the experience of the transdisciplinary tobacco use research centers. Nicotine Tob Res 2003;5 Suppl 1:S11–S9.
    OpenUrlAbstract
  2. 2.↵
    1. Warnecke RB,
    2. Oh A,
    3. Breen N,
    4. Gehlert S,
    5. Paskett E,
    6. Tucker KL,
    7. et al.
    Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities. Am J Public Health 2008;98:1608–15.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Patterson RE,
    2. Colditz GA,
    3. Hu FB,
    4. Schmitz KH,
    5. Ahima RS,
    6. Brownson RC,
    7. et al.
    The 2011–2016 Transdisciplinary Research on Energetics and Cancer (TREC) initiative: rationale and design. Cancer Causes Control 2013;24:695–704.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Hesse BW,
    2. Johnson LE,
    3. Davis KL
    . Extending the reach, effectiveness, and efficiency of communication: evidence from the centers of excellence in cancer communication research. Patient Educ Couns 2010;81(Suppl):S1–S5.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Rosenfield PL
    . The potential of transdisciplinary research for sustaining and extending linkages between the health and social sciences. Soc Sci Med 1992;35:1343–57.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Emmons KM,
    2. Viswanath K,
    3. Colditz GA
    . The role of transdisciplinary collaboration in translating and disseminating health research: lessons learned and exemplars of success. Am J Prev Med 2008;35:S204–10.
    OpenUrlCrossRefPubMed
  7. 7.↵
    Transdisciplinary Research on Energetics and Cancer (TREC) [homepage on the Internet]. Seattle, WA: TREC Coordination Center, Fred Hutchison Cancer Research Center [updated 2015 Nov 1; cited 2015 Oct 21]. Available from: www.trecscience.org.
  8. 8.↵
    1. Vogel AL,
    2. Feng A,
    3. Oh A,
    4. Hall KL,
    5. Stipelman BA,
    6. Stokols D,
    7. et al.
    Influence of a National Cancer Institute transdisciplinary research and training initiative on trainees' transdisciplinary research competencies and scholarly productivity. Transl Behav Med 2012;2:459–68.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Benesh EC,
    2. Gill J,
    3. Lamb LE,
    4. Moley KH
    . Maternal obesity, cage density, and age contribute to prostate hyperplasia in mice. Reprod Sci 2016;23:176–85.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Colditz GA,
    2. Rosner B
    . Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am J Epidemiol 2000;152:950–64.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Pike MC,
    2. Krailo MD,
    3. Henderson BE,
    4. Casagrande JT,
    5. Hoel DG
    . ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer. Nature 1983;303:767–70.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Rosner B,
    2. Colditz GA
    . Nurses' health study: log-incidence mathematical model of breast cancer incidence. J Natl Cancer Inst 1996;88:359–64.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Yang XR,
    2. Sherman ME,
    3. Rimm DL,
    4. Lissowska J,
    5. Brinton LA,
    6. Peplonska B,
    7. et al.
    Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev 2007;16:439–43.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Ursin G,
    2. Bernstein L,
    3. Lord SJ,
    4. Karim R,
    5. Deapen D,
    6. Press MF,
    7. et al.
    Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer 2005;93:364–71.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Colditz GA,
    2. Rosner BA,
    3. Chen WY,
    4. Holmes MD,
    5. Hankinson SE
    . Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst 2004;96:218–28.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Althuis MD,
    2. Fergenbaum JH,
    3. Garcia-Closas M,
    4. Brinton LA,
    5. Madigan MP,
    6. Sherman ME
    . Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev 2004;13:1558–68.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Liu Y,
    2. Colditz GA,
    3. Rosner B,
    4. Berkey CS,
    5. Collins LC,
    6. Schnitt SJ,
    7. et al.
    Alcohol intake between menarche and first pregnancy: a prospective study of breast cancer risk. J Natl Cancer Inst 2013;105:1571–8.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Wu Y,
    2. Zhang D,
    3. Kang S
    . Physical activity and risk of breast cancer: a meta-analysis of prospective studies. Breast Cancer Res Treat 2013;137:869–82.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Neilson HK,
    2. Conroy SM,
    3. Friedenreich CM
    . The influence of energetic factors on biomarkers of postmenopausal breast cancer risk. Curr Nutr Rep 2014;3:22–34.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Thompson HJ,
    2. Westerlind KC,
    3. Snedden J,
    4. Briggs S,
    5. Singh M
    . Exercise intensity dependent inhibition of 1-methyl-1-nitrosourea induced mammary carcinogenesis in female F-344 rats. Carcinogenesis 1995;16:1783–6.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Thompson HJ
    . Effects of physical activity and exercise on experimentally-induced mammary carcinogenesis. Breast Cancer Res Treat 1997;46:135–41.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Field LA,
    2. Love B,
    3. Deyarmin B,
    4. Hooke JA,
    5. Shriver CD,
    6. Ellsworth RE
    . Identification of differentially expressed genes in breast tumors from African American compared with Caucasian women. Cancer 2012;118:1334–44.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Iaffaioli RV,
    2. Frasci G,
    3. Rinaldi L,
    4. Del Vecchio L,
    5. Tortoriello A,
    6. Facchini G,
    7. et al.
    Value of the CD25+ CD16+ cell determination in defining the prognosis of operable breast cancer patients. Eur J Gynaecol Oncol 1993;14:412–8.
    OpenUrlPubMed
  24. 24.↵
    1. Martin DN,
    2. Boersma BJ,
    3. Yi M,
    4. Reimers M,
    5. Howe TM,
    6. Yfantis HG,
    7. et al.
    Differences in the tumor microenvironment between African-American and European-American breast cancer patients. PLoS One 2009;4:e4531.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Morris GJ,
    2. Mitchell EP
    . Higher incidence of aggressive breast cancers in African-American women: a review. J Natl Med Assoc 2008;100:698–702.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Baumgarten SC,
    2. Frasor J
    . Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers. Mol Endocrinol 2012;26:360–71.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Cleary MP,
    2. Grossmann ME
    . Minireview: Obesity and breast cancer: the estrogen connection. Endocrinology 2009;150:2537–42.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Wang Y,
    2. Beydoun MA
    . The obesity epidemic in the United States–gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 2007;29:6–28.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Bruce MA,
    2. Sims M,
    3. Miller S,
    4. Elliott V,
    5. Ladipo M
    . One size fits all? Race, gender and body mass index among U.S. adults. J Natl Med Assoc 2007;99:1152–8.
    OpenUrlPubMed
  30. 30.↵
    1. Robinson WR,
    2. Gordon-Larsen P,
    3. Kaufman JS,
    4. Suchindran CM,
    5. Stevens J
    . The female-male disparity in obesity prevalence among black American young adults: contributions of sociodemographic characteristics of the childhood family. Am J Clin Nutr 2009;89:1204–12.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Flegal KM,
    2. Carroll MD,
    3. Kit BK,
    4. Ogden CL
    . Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 2012;307:491–7.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Menashe I,
    2. Anderson WF,
    3. Jatoi I,
    4. Rosenberg PS
    . Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis. J Natl Cancer Inst 2009;101:993–1000.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Wright JL,
    2. Reis IM,
    3. Zhao W,
    4. Panoff JE,
    5. Takita C,
    6. Sujoy V,
    7. et al.
    Racial disparity in estrogen receptor positive breast cancer patients receiving trimodality therapy. Breast 2012;21:276–83.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Gehlert S,
    2. Hall K,
    3. Vogel A,
    4. Hohl S,
    5. Hartman S,
    6. Nebeling L,
    7. et al.
    Advancing transdisciplinary research: the Transdisciplinary Research on Energetics and Cancer Initiative. J Transl Med Epidemiol 2014;2:1032.
    OpenUrlPubMed
  35. 35.↵
    1. Stokols D,
    2. Misra S,
    3. Moser RP,
    4. Hall KL,
    5. Taylor BK
    . The ecology of team science: understanding contextual influences on transdisciplinary collaboration. Am J Prev Med 2008;35:S96–115.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Stokols D,
    2. Hall KL,
    3. Taylor BK,
    4. Moser RP
    . The science of team science: overview of the field and introduction to the supplement. Am J Prev Med 2008;35:S77–89.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Hall KL,
    2. Feng AX,
    3. Moser RP,
    4. Stokols D,
    5. Taylor BK
    . Moving the science of team science forward: collaboration and creativity. Am J Prev Med 2008;35:S243–9.
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. Hall KL,
    2. Stokols D,
    3. Moser RP,
    4. Taylor BK,
    5. Thornquist MD,
    6. Nebeling LC,
    7. et al.
    The collaboration readiness of transdisciplinary research teams and centers findings from the National Cancer Institute's TREC Year-One evaluation study. Am J Prev Med 2008;35:S161–72.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Masse LC,
    2. Moser RP,
    3. Stokols D,
    4. Taylor BK,
    5. Marcus SE,
    6. Morgan GD,
    7. et al.
    Measuring collaboration and transdisciplinary integration in team science. Am J Prev Med 2008;35:S151–60.
    OpenUrlCrossRefPubMed
  40. 40.↵
    1. Pohl C,
    2. Hirsch Hadorn G
    . Principles for designing transdisciplinary research. Proposed by the Swiss Academies of Arts and Sciences. Munich, Germany: Oekom Verlag; 2007.
  41. 41.↵
    1. Gray B
    . Enhancing transdisciplinary research through collaborative leadership. Am J Prev Med 2008;35:S124–32.
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top
Clinical Cancer Research: 22 (7)
April 2016
Volume 22, Issue 7
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
TREC to WHERE? Transdisciplinary Research on Energetics and Cancer
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
TREC to WHERE? Transdisciplinary Research on Energetics and Cancer
Kathryn H. Schmitz, Sarah Gehlert, Ruth E. Patterson, Graham A. Colditz, Jorge E. Chavarro, Frank B. Hu, Marian L. Neuhouser, Kathleen M. Sturgeon, Mark Thornquist, Deirdre Tobias and Linda C. Nebeling
Clin Cancer Res April 1 2016 (22) (7) 1565-1571; DOI: 10.1158/1078-0432.CCR-14-1214

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
TREC to WHERE? Transdisciplinary Research on Energetics and Cancer
Kathryn H. Schmitz, Sarah Gehlert, Ruth E. Patterson, Graham A. Colditz, Jorge E. Chavarro, Frank B. Hu, Marian L. Neuhouser, Kathleen M. Sturgeon, Mark Thornquist, Deirdre Tobias and Linda C. Nebeling
Clin Cancer Res April 1 2016 (22) (7) 1565-1571; DOI: 10.1158/1078-0432.CCR-14-1214
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Examples of TREC Projects
    • TREC Framework and Future Directions
    • Conclusions
    • Disclosure of Potential Conflicts of Interest
    • Grant Support
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • The Changing Landscape of Therapeutic Cancer Vaccines
  • Intratumoral Immunotherapy: Trials & Practice
  • Siglec-15 in Cancer Immunotherapy
Show more Review
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement